These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22587365)

  • 21. Association between the metabolic syndrome and newly diagnosed coronary artery disease.
    Baltali M; Gokcel A; Kiziltan HT; Korkmaz ME; Topcu S; Yalcin F; Demircan S; Yigit F; Ozin B; Muderrisoglu IH
    Diabetes Nutr Metab; 2003 Jun; 16(3):169-75. PubMed ID: 14635734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fasting serum concentration of apolipoprotein B48 represents residual risks in patients with new-onset and chronic coronary artery disease.
    Mori K; Ishida T; Yasuda T; Monguchi T; Sasaki M; Kondo K; Hasokawa M; Nakajima H; Haraguchi Y; Sun L; Shinohara M; Toh R; Nishimura K; Hirata K
    Clin Chim Acta; 2013 Jun; 421():51-6. PubMed ID: 23428589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is increased apolipoprotein B-A major factor enhancing the risk of coronary artery disease in type 2 diabetes?
    Snehalatha C; Ramachandran A; Sivasankari S; Satyavani K; Viswanathan V; Misra J; Girinath MR; Sathyamurthy I
    J Assoc Physicians India; 2002 Aug; 50():1036-8. PubMed ID: 12421026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum apolipoprotein B-48 levels are correlated with carotid intima-media thickness in subjects with normal serum triglyceride levels.
    Nakatani K; Sugimoto T; Masuda D; Okano R; Oya T; Monden Y; Yamashita T; Kawase R; Nakaoka H; Inagaki M; Yuasa-Kawase M; Tsubakio-Yamamoto K; Ohama T; Nishida M; Ishigami M; Komuro I; Yamashita S
    Atherosclerosis; 2011 Sep; 218(1):226-32. PubMed ID: 21641598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulse wave velocity and coronary risk stratification.
    Mendonça MI; Reis RP; Sousa AC; Gomes S; Faria P; Pereira A; Silva B; Serrão M; Santos N; Sousa FS; Silva JA; Sousa J; Ornelas I; Freitas S; Cardoso A; Araújo JJ
    Rev Port Cardiol; 2009 Feb; 28(2):155-71. PubMed ID: 19438151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertriglyceridemic subjects exhibit an accumulation of small dense chylomicron particles in the fasting state.
    Irawati D; Mamo JC; Soares MJ; Slivkoff-Clark KM; James AP
    Atherosclerosis; 2015 Nov; 243(1):236-41. PubMed ID: 26407667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased serum apolipoprotein B48 concentration in patients with metabolic syndrome.
    Kinoshita M; Ohnishi H; Maeda T; Yoshimura N; Takeoka Y; Yasuda D; Kusano J; Mashimo Y; Saito S; Shimamoto K; Teramoto T
    J Atheroscler Thromb; 2009 Aug; 16(4):517-22. PubMed ID: 19713673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired fasting glucose and the prevalence and severity of angiographic coronary artery disease in high-risk Chinese patients.
    Dong X; Zhou L; Zhai Y; Lu B; Wang D; Shi H; Luo X; Fan W; Hu R
    Metabolism; 2008 Jan; 57(1):24-9. PubMed ID: 18078855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum copper and zinc concentrations are lower in Iranian patients with angiographically defined coronary artery disease than in subjects with a normal angiogram.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Parizadeh MR; Aghacizadeh R; Ferns GA
    J Trace Elem Med Biol; 2007; 21(1):22-8. PubMed ID: 17317522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reference interval for the apolipoprotein B-48 concentration in healthy Japanese individuals.
    Masuda D; Nishida M; Arai T; Hanada H; Yoshida H; Yamauchi-Takihara K; Moriyama T; Tada N; Yamashita S
    J Atheroscler Thromb; 2014; 21(6):618-27. PubMed ID: 24573016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fasting serum apolipoprotein B-48 can be a marker of postprandial hyperlipidemia.
    Masuda D; Sakai N; Sugimoto T; Kitazume-Taneike R; Yamashita T; Kawase R; Nakaoka H; Inagaki M; Nakatani K; Yuasa-Kawase M; Tsubakio-Yamamoto K; Ohama T; Nakagawa-Toyama Y; Nishida M; Ishigami M; Masuda Y; Matsuyama A; Komuro I; Yamashita S
    J Atheroscler Thromb; 2011; 18(12):1062-70. PubMed ID: 21946533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-hour post-challenge hyperglycemia, but not fasting plasma glucose, associated with severity of coronary artery disease in patients with angina.
    Fu CP; Sheu WH; Lee WL; Lee WJ; Wang JS; Lin SY; Lee IT
    PLoS One; 2018; 13(8):e0202280. PubMed ID: 30110378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease.
    Sposito AC; Santos RD; Hueb W; Ventura LI; Vinagre CC; Ramires JA; Maranhão RC
    Atherosclerosis; 2002 Apr; 161(2):447-53. PubMed ID: 11888530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome.
    Irawati D; Mamo JC; Dhaliwal SS; Soares MJ; Slivkoff-Clark KM; James AP
    Lipids Health Dis; 2016 Sep; 15(1):169. PubMed ID: 27686975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fasting adiponectin is inversely correlated with metabolic syndrome in patients with coronary artery disease.
    Wang JH; Lee CJ; Lee CC; Chen YC; Lee RP; Hsu BG
    Intern Med; 2010; 49(8):739-47. PubMed ID: 20424363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study.
    Katzmann JL; Werner CM; Stojakovic T; März W; Scharnagl H; Laufs U
    Lipids Health Dis; 2020 May; 19(1):116. PubMed ID: 32473635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular risk and atherosclerosis prevention.
    Frohlich J; Al-Sarraf A
    Cardiovasc Pathol; 2013; 22(1):16-8. PubMed ID: 22502868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasting but not postprandial (postmeal) glycemia predicts the risk of death in subjects with coronary artery disease.
    Nigam A; Bourassa MG; Fortier A; Guertin MC; Tardif JC
    Can J Cardiol; 2007 Sep; 23(11):873-8. PubMed ID: 17876378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studying the Relation of Postprandial Triglyceride with Coronary Artery Disease (CAD).
    Manochehri M; Moghadam AJ
    Med Arch; 2016 Jul; 70(4):261-264. PubMed ID: 27703285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lipid and carbohydrate disturbances in men with coronary artery disease according to age].
    Stasiakowska-Badura E; Kochmański M
    Pol Arch Med Wewn; 2006 Oct; 116(4):955-64. PubMed ID: 18416297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.